WuXi Biologics (Cayman) Inc. (HKG:2269)
23.25
+0.05 (0.22%)
May 13, 2025, 2:45 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 94.43 billion as of May 12, 2025. Its market cap has increased by 66.79% in one year.
Market Cap
94.43B
Enterprise Value
92.19B
Revenue
19.87B
Ranking
n/a
PE Ratio
27.84
Stock Price
23.25
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 94.43B, an increase of 194.75%. That is a compound annual growth rate of 14.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 194.78B |
Hansoh Pharmaceutical Group Company | 130.51B |
JD Health International | 121.51B |
Alibaba Health Information Technology | 84.76B |
Innovent Biologics | 81.49B |
Akeso | 75.71B |
Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |
Sino Biopharmaceutical | 68.71B |